Source: SEC

Cardionomic: Cardionomic received $15.8M in Equity Funding

Read full article »

Cardionomic's Competitors | Cardionomic's News | Cardionomic's Financials

Followers on Owler

5

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

Steve Goedeke's photo - President & CEO of Cardionomic

President & CEO

Steve Goedeke

CEO Approval Rating

86/100

Cardionomic is a biotechnology company that develops catheter-based neuromodulation therapy for the treatment of ADHF.